BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 307060)

  • 1. Modification of electroshock convulsive responses and thresholds in neonatal rats after brain monoamine reduction.
    London ED; Buterbaugh GG
    J Pharmacol Exp Ther; 1978 Jul; 206(1):81-90. PubMed ID: 307060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-dependent reduction in maximum electroshock convulsive threshold associated with decreased concentrations of brain monoamines.
    London ED; Waller SB; Vocci FJ; Buterbaugh GG
    Pharmacol Biochem Behav; 1982 Mar; 16(3):441-7. PubMed ID: 6979051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Convulsive thresholds and severity and the anticonvulsant effect of phenobarbital and phenytoin in adult rats administered 6-hydroxydopamine or 5,7-dihydroxytryptamine during postnatal development.
    Waller SB; Buterbaugh GG
    Pharmacol Biochem Behav; 1985 Sep; 23(3):473-8. PubMed ID: 3931103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tonic convulsive thresholds and responses during the postnatal development of rats administered 6-hydroxydopamine or 5,7-dihydroxytryptamine within three days following birth.
    Waller SB; Buterbaugh GG
    Pharmacol Biochem Behav; 1983 Dec; 19(6):973-8. PubMed ID: 6419239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetrabenazine, an amine-depleting drug, also blocks dopamine receptors in rat brain.
    Reches A; Burke RE; Kuhn CM; Hassan MN; Jackson VR; Fahn S
    J Pharmacol Exp Ther; 1983 Jun; 225(3):515-21. PubMed ID: 6864517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of monoamine neural systems in L-dihydroxyphenylalanine-stimulated activity.
    Hollister AS; Breese GR; Mueller RA
    J Pharmacol Exp Ther; 1979 Jan; 208(1):37-43. PubMed ID: 759613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reserpine-induced alterations in brain amines and their relationship to changes in the incidence of minimal electroshock seizures in mice.
    Azzaro AJ; Wenger GR; Craig CR; Stitzel RE
    J Pharmacol Exp Ther; 1972 Mar; 180(3):558-68. PubMed ID: 4258979
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification of nonserotonergic [3H]ketanserin binding sites associated with nerve terminals in rat brain and with platelets; relation with release of biogenic amine metabolites induced by ketanserin- and tetrabenazine-like drugs.
    Leysen JE; Eens A; Gommeren W; van Gompel P; Wynants J; Janssen PA
    J Pharmacol Exp Ther; 1988 Jan; 244(1):310-21. PubMed ID: 3336007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of biogenic amines in the reserpine-induced alteration of minimal electroshock seizure thresholds in the mouse.
    Wenger GR; Stitzel RE; Craig CR
    Neuropharmacology; 1973 Jul; 12(7):693-703. PubMed ID: 4147164
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of reserpine, iproniazid and L-dopa on electrically-induced spinal cord seizures.
    Jobe PC; Ray TB
    Res Commun Chem Pathol Pharmacol; 1980 Sep; 29(3):417-27. PubMed ID: 7423021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional brain 3H-digitoxigenin and monoamine content during the development of convulsions produced by system digitoxigenin.
    Vocci FJ; Rhody JM; London ED; Buterbaugh GG
    Res Commun Chem Pathol Pharmacol; 1980 Aug; 29(2):251-63. PubMed ID: 7414048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between magnitude of electroshock stimulation and the effects of digitoxigenin, pentylenetetrazol and brain monoamine reduction on electroshock convulsive thresholds.
    Buterbaugh GG; London ED
    Neuropharmacology; 1977 Sep; 16(9):617-23. PubMed ID: 144247
    [No Abstract]   [Full Text] [Related]  

  • 13. Correlation between brain monoamine levels and postictal coma following electroshock.
    Fukuda T; Araki Y; Takishita S; Koga T
    Arch Int Pharmacodyn Ther; 1975 Jan; 213(1):58-63. PubMed ID: 1156019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of the intracisternal administration of the neurotoxins 6-hydroxydopamine and 5,7-dihydroxytryptamine on the formation of the passive avoidance reaction and the biogenic amine level in the brain of rats].
    Shabanov PD; Bul'on VV; Lénárd L
    Fiziol Zh SSSR Im I M Sechenova; 1988 Jul; 74(7):920-3. PubMed ID: 3141223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of tryptaminergic drugs on electroshock fighting behaviour in rats.
    Anand M; Gupta GP; Bhargava KP
    Eur J Pharmacol; 1976 Oct; 39(2):389-91. PubMed ID: 135690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-lasting antiepileptic effects of levetiracetam against epileptic seizures in the spontaneously epileptic rat (SER): differentiation of levetiracetam from conventional antiepileptic drugs.
    Ji-qun C; Ishihara K; Nagayama T; Serikawa T; Sasa M
    Epilepsia; 2005 Sep; 46(9):1362-70. PubMed ID: 16146430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brainstem seizure severity regulates forebrain seizure expression in the audiogenic kindling model.
    Merrill MA; Clough RW; Jobe PC; Browning RA
    Epilepsia; 2005 Sep; 46(9):1380-8. PubMed ID: 16146432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteration of seizures resulting from pinealectomy in the rat after neonatal treatment with 6-hydroxydopamine.
    Stockmeier CA; Larsen BR; Blask DE
    J Neurosci Res; 1985; 14(2):279-84. PubMed ID: 3930758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological and ultrastructural maturation of serotonergic synapses during ontogeny.
    Tissari AH
    Med Biol; 1975 Feb; 53(1):1-14. PubMed ID: 1095838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The influence of central monoaminergic systems on the anticonvulsive action of propranolol].
    Lasek R; Fischer W; Müller M
    Pharmazie; 1986 Feb; 41(2):128-30. PubMed ID: 2941769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.